Trial intelligence / Profile preview

Antibiotic Prophylaxis in Prosthetic Breast Reconstructions

NCT02012517Phase 4Unknown

Sponsor
Sheba Medical Center
Start
Jan 2014
Primary completion
Dec 2016
Modality
Reversible Covalent Inhibitors
Countries
1
01

Overview

A Phase 4 trial of cefazolin, cefalexin in surgical site infection (SSI), sponsored by Sheba Medical Center. Status: unknown.

02

Drugs

cefazolincefalexin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02012517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02012517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call